The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight ...

Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...

Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...

A live survey conducted during the "European Health Check" revealed that 77% of participants do not believe the current ...

FRANKFURT, Germany, Nov. 26, 2024 /PRNewswire/ -- Zentiva AG, a wholly-owned subsidiary of Zentiva Pharma GmbH, headquartered in Frankfurt am Main, Germany, and part of Zentiva group ("Zentiva ...

Biocon said that the company and Zentiva, its European partner, have received a de-centralized procedure (DCP) approval for its complex formulation, Liraglutide, in the European Union (EU).

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...

Biocon Limited, alongside its European partner Zentiva, has successfully obtained approval for their generic version of ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...